DSpace at KIST

Browsing byAuthorCho, Hanhee

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
가 나 다 라 마 바 사 아 자 차 카 타 파 하
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 10 of 10

Issue DateTitleAuthor(s)
2019-12A Comparative Study on Albumin-Binding Molecules for Targeted Tumor Delivery through Covalent and Noncovalent ApproachUm, Wooram; Park, Jooho; Youn, Ahye; Cho, Hanhee; Lim, Seungho; Lee, Jong Won; Yoon, Hong Yeol; Lim, Dong-Kwon; Park, Jae Hyung; Kim, Kwangmeyung
2023-10All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapySong, Sukyung; Shim, Man Kyu; Yang, Suah; Lee, Jaewan; Yun, Wan Su; Cho, Hanhee; Moon, Yujeong; Min, Jin Young; Han, Eun Hee; Yoon, Hong Yeol; Kim, Kwangmeyung
2022-05Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell deathMoon, Yujeong; Shim, Man Kyu; Choi, Jiwoong; Yang, Suah; Kim, Jinseong; Yun, Wan Su; Cho, Hanhee; Park, Jung Yeon; Kim, Yongju; Seong, Joon-Kyung; Kim, Kwangmeyung
2024-03Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapyKim, Jinseong; Shim, Man Kyu; Moon, Yujeong; Kim, Jeongrae; Cho, Hanhee; Yun, Wan Su; Shim, Nayeon; Seong, Joon-Kyung; Lee, Yonghyun; Lim, Dong-Kwon; Kim, Kwangmeyung
2020-12Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapyShim, Man Kyu; Moon, Yujeong; Yang, Suah; Kim, Jinseong; Cho, Hanhee; Lim, Seungho; Yoon, Hong Yeol; Seong, Joon-Kyung; Kim, Kwangmeyung
2022-01Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted TherapyCho, Hanhee; Shim, Man Kyu; Yang, Suah; Song, Sukyung; Moon, Yujeong; Kim, Jinseong; Byun, Youngro; Ahn, Cheol-Hee; Kim, Kwangmeyung
2022-04Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical TranslationCho, Hanhee; Jeon, Seong Ik; Ahn, Cheol-Hee; Shim, Man Kyu; Kim, Kwangmeyung
2023-04In situ albumin-binding and esterase-specifically cleaved BRD4-degrading PROTAC for targeted cancer therapyCho, Hanhee; Jeon, Seong Ik; Shim, Man Kyu; Ahn, Cheol-Hee; Kim, Kwangmeyung
2022-03Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune ResponsesKim, Jeongrae; Choi, Yongwhan; Yang, Suah; Lee, Jaewan; Choi, Jiwoong; Moon, Yujeong; Kim, Jinseong; Shim, Nayeon; Cho, Hanhee; Shim, Man Kyu; Jeon, Sangmin; Lim, Dong-Kwon; Yoon, Hong Yeol; Kim, Kwangmeyung
2021-07-27Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer ImmunotherapyChoi, Jiwoong; Shim, Man Kyu; Yang, Suah; Hwang, Hee Sook; Cho, Hanhee; Kim, Jeongrae; Yun, Wan Su; Moon, Yujeong; Kim, Jinseong; Yoon, Hong Yeol; Kim, Kwangmeyung
1

BROWSE